Sharon Benzeno

ADPT

CHIEF BUSINESS DEVELOPMENT OFF · ADAPTIVE BIOTECHNOLOGIES CORP · CIK 0001780854

FILING MIX · LIFETIME40%/60%

BUYS

SELLS

117

TOTAL VALUE

$37.60M

COMPANIES

ACTIVE SINCE

Feb 2020

HOLDINGS NOW

37,416

AVG SELL PX

$23.35

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

47 backtested trades · 8 horizons · 11 pendingHow are these numbers computed? →

Forward-return performance of every backtestable P/S trade by Sharon Benzeno, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.

HORIZON	TRADES	WIN RATE	INSIDER RETURN	SPY RETURN	MEAN EXCESS	MEDIAN EXCESS	T-STAT
7d	47	+48.94%	-1.64%	+0.74%	-2.38%	-0.96%	-1.75
14d	47	+53.19%	-1.41%	+1.83%	-3.25%	-3.12%	-1.73
30d	47	+59.57%	-4.01%	+2.06%	-6.06%	-4.79%	-2.41
60d	47	+65.96%	-6.33%	+5.09%	-11.43%	-15.53%	-3.51
90d	47	+51.06%	-4.99%	+7.89%	-12.88%	-9.27%	-3.60
180d	47(1 pending)	+65.22%	-6.02%	+16.20%	-22.07%	-36.58%	-4.30
1y	47(4 pending)	+90.70%	-27.73%	+26.76%	-54.49%	-66.51%	-7.17
2y	47(6 pending)	+95.12%	-60.91%	+17.41%	-78.33%	-94.70%	-5.97

How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.

Holdings over time

ADPT · 37,416 shares · as of Jun 29, 2026

Trading cadence · quarterly flow

BUY ● SELL ●

2020

2021

2022

2023

2024

2025

2026

FLOW · 79 buys / 117 sellsCOVERAGE · 26 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED	DETAILS
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Commercial Ofc Imm Med	1,837	—	—	0	Jun 29, 2026	Jun 30, 2026 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Commercial Ofc Imm Med	24,944	$3.99	$99.5K	324,476	Jun 29, 2026	Jun 30, 2026 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Commercial Ofc Imm Med	51,570	—	—	113,457	Jun 29, 2026	Jun 30, 2026 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE10b5-1 10b5-1 plan	154,768	$21.14	$3.27M	221,278	Jun 29, 2026	Jun 30, 2026 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Commercial Ofc Imm Med	51,570	$8.12	$418.7K	376,046	Jun 29, 2026	Jun 30, 2026 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Commercial Ofc Imm Med	24,944	$8.46	$211.0K	299,532	Jun 29, 2026	Jun 30, 2026 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Commercial Ofc Imm Med	24,944	—	—	37,416	Jun 29, 2026	Jun 30, 2026 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Commercial Ofc Imm Med	24,944	—	—	87,303	Jun 29, 2026	Jun 30, 2026 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Commercial Ofc Imm Med	1,837	$12.14	$22.3K	274,588	Jun 29, 2026	Jun 30, 2026 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Commercial Ofc Imm Med	11,034	—	—	1,837	Jun 26, 2026	Jun 30, 2026 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Commercial Ofc Imm Med	11,034	$12.14	$134.0K	283,785	Jun 26, 2026	Jun 30, 2026 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE10b5-1 10b5-1 plan	11,034	$21.00	$231.7K	272,751	Jun 26, 2026	Jun 30, 2026 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Commercial Ofc Imm Med	63,103	$13.17	$831.1K	272,751	Mar 11, 2026	Mar 13, 2026 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASEGRANT Stock grant	39,063	—	—	335,854	Mar 4, 2026	Mar 6, 2026 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Commercial Ofc Imm Med	4,290	—	—	12,871	Dec 4, 2025	Dec 8, 2025 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Commercial Ofc Imm Med	4,157	—	—	62,360	Dec 4, 2025	Dec 8, 2025 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE10b5-1 10b5-1 plan	12,604	$16.85	$212.4K	296,791	Dec 4, 2025	Dec 8, 2025 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Commercial Ofc Imm Med	4,157	$8.46	$35.2K	305,238	Dec 4, 2025	Dec 8, 2025 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Commercial Ofc Imm Med	4,290	$12.14	$52.1K	301,081	Dec 4, 2025	Dec 8, 2025 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Commercial Ofc Imm Med	4,157	$3.99	$16.6K	309,395	Dec 4, 2025	Dec 8, 2025 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Commercial Ofc Imm Med	4,157	—	—	112,247	Dec 4, 2025	Dec 8, 2025 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Commercial Ofc Imm Med	34,375	—	—	0	Nov 21, 2025	Nov 24, 2025 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Commercial Ofc Imm Med	20,834	$6.55	$136.5K	318,459	Nov 21, 2025	Nov 24, 2025 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Commercial Ofc Imm Med	49,480	$6.55	$324.1K	367,939	Nov 21, 2025	Nov 24, 2025 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE10b5-1 10b5-1 plan	308,477	$16.91	$5.22M	296,791	Nov 21, 2025	Nov 24, 2025 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Commercial Ofc Imm Med	20,834	—	—	0	Nov 21, 2025	Nov 24, 2025 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Commercial Ofc Imm Med	834	—	—	0	Nov 21, 2025	Nov 24, 2025 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Commercial Ofc Imm Med	119,809	$12.14	$1.45M	522,123	Nov 21, 2025	Nov 24, 2025 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Commercial Ofc Imm Med	34,375	$7.27	$249.9K	402,314	Nov 21, 2025	Nov 24, 2025 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Commercial Ofc Imm Med	83,145	$3.99	$331.7K	605,268	Nov 21, 2025	Nov 24, 2025 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Commercial Ofc Imm Med	119,809	—	—	17,161	Nov 21, 2025	Nov 24, 2025 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Commercial Ofc Imm Med	834	$6.27	$5.2K	297,625	Nov 21, 2025	Nov 24, 2025 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Commercial Ofc Imm Med	49,480	—	—	0	Nov 21, 2025	Nov 24, 2025 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Commercial Ofc Imm Med	83,145	—	—	116,404	Nov 21, 2025	Nov 24, 2025 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Commercial Ofc Imm Med	68,961	$12.14	$837.2K	594,716	Nov 20, 2025	Nov 24, 2025 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Commercial Ofc Imm Med	68,961	—	—	136,970	Nov 20, 2025	Nov 24, 2025 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE10b5-1 10b5-1 plan	297,925	$16.54	$4.93M	296,791	Nov 20, 2025	Nov 24, 2025 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Commercial Ofc Imm Med	133,032	—	—	66,517	Nov 20, 2025	Nov 24, 2025 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Commercial Ofc Imm Med	133,032	$8.46	$1.13M	525,755	Nov 20, 2025	Nov 24, 2025 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Commercial Ofc Imm Med	3,065	$6.99	$21.4K	392,723	Mar 5, 2025	Mar 6, 2025 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Commercial Ofc Imm Med	41,600	$6.98	$290.4K	395,788	Mar 5, 2025	Mar 6, 2025 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASEGRANT Stock grant	165,027	—	—	165,027	Mar 4, 2025	Mar 6, 2025 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASEGRANT Stock grant	109,973	—	—	437,388	Mar 4, 2025	Mar 6, 2025 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Commercial Ofc Imm Med	10,746	$3.43	$36.9K	346,059	Mar 5, 2024	Mar 6, 2024 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Commercial Ofc Imm Med	18,644	$3.44	$64.1K	327,415	Mar 5, 2024	Mar 6, 2024 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASEGRANT Stock grant	132,979	—	—	356,805	Mar 4, 2024	Mar 6, 2024 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASEGRANT Stock grant	199,549	—	—	199,549	Mar 4, 2024	Mar 6, 2024 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASEGRANT Stock grant	199,549	—	—	199,549	Mar 6, 2023	Mar 8, 2023 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASEGRANT Stock grant	132,979	—	—	235,575	Mar 6, 2023	Mar 8, 2023 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Commercial Ofc Imm Med	11,749	$8.57	$100.7K	223,826	Mar 6, 2023	Mar 8, 2023 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	2,670	$12.01	$32.1K	102,596	Mar 7, 2022	Mar 8, 2022 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASEGRANT Stock grant	205,931	—	—	205,931	Mar 4, 2022	Mar 8, 2022 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASEGRANT Stock grant	82,372	—	—	105,266	Mar 4, 2022	Mar 8, 2022 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	1,014	$41.85	$42.4K	22,894	Mar 15, 2021	Mar 17, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	1,354	$31.71	$42.9K	24,248	Mar 15, 2021	Mar 17, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	1,354	—	—	47,396	Mar 15, 2021	Mar 17, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	340	$41.22	$14.0K	23,908	Mar 15, 2021	Mar 17, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASEGRANT Stock grant	57,234	—	—	57,234	Mar 4, 2021	Mar 8, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASEGRANT Stock grant	22,894	—	—	22,894	Mar 4, 2021	Mar 8, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	1,563	—	—	34,375	Mar 1, 2021	Mar 3, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	2,604	—	—	20,834	Mar 1, 2021	Mar 3, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	6,210	$57.57	$357.5K	561	Mar 1, 2021	Mar 3, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	2,604	$6.55	$17.1K	2,604	Mar 1, 2021	Mar 3, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	2,604	$6.55	$17.1K	5,208	Mar 1, 2021	Mar 3, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	561	$58.17	$32.6K	0	Mar 1, 2021	Mar 3, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	1,563	$7.27	$11.4K	6,771	Mar 1, 2021	Mar 3, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	2,604	—	—	49,480	Mar 1, 2021	Mar 3, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	416	—	—	834	Feb 19, 2021	Mar 3, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	416	$6.27	$2.6K	416	Feb 19, 2021	Mar 3, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	416	$61.20	$25.5K	0	Feb 19, 2021	Mar 3, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	16,250	—	—	48,750	Feb 16, 2021	Feb 17, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	16,250	$31.71	$515.3K	16,250	Feb 16, 2021	Feb 17, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	9,528	$65.29	$622.1K	0	Feb 16, 2021	Feb 17, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	1,700	$64.59	$109.8K	9,528	Feb 16, 2021	Feb 17, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	5,022	$63.42	$318.5K	11,228	Feb 16, 2021	Feb 17, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	6,470	$55.61	$359.8K	300	Feb 1, 2021	Feb 3, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	2,604	—	—	52,084	Feb 1, 2021	Feb 3, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	300	$56.41	$16.9K	0	Feb 1, 2021	Feb 3, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	2,604	$6.55	$17.1K	5,208	Feb 1, 2021	Feb 3, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	2,604	—	—	23,438	Feb 1, 2021	Feb 3, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	1,562	—	—	35,938	Feb 1, 2021	Feb 3, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	2,604	$6.55	$17.1K	2,604	Feb 1, 2021	Feb 3, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	1,562	$7.27	$11.4K	6,770	Feb 1, 2021	Feb 3, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	417	$69.00	$28.8K	0	Jan 19, 2021	Jan 20, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	417	—	—	1,250	Jan 19, 2021	Jan 20, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	417	$6.27	$2.6K	417	Jan 19, 2021	Jan 20, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	2,604	$6.55	$17.1K	5,208	Jan 4, 2021	Jan 6, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	2,209	$56.12	$124.0K	4,562	Jan 4, 2021	Jan 6, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	495	$58.63	$29.0K	267	Jan 4, 2021	Jan 6, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	1,563	$7.27	$11.4K	6,771	Jan 4, 2021	Jan 6, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	267	$59.46	$15.9K	0	Jan 4, 2021	Jan 6, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	3,800	$57.82	$219.7K	762	Jan 4, 2021	Jan 6, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	2,604	—	—	54,688	Jan 4, 2021	Jan 6, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	2,604	—	—	26,042	Jan 4, 2021	Jan 6, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	1,563	—	—	37,500	Jan 4, 2021	Jan 6, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	2,604	$6.55	$17.1K	2,604	Jan 4, 2021	Jan 6, 2021 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	417	—	—	1,667	Dec 21, 2020	Dec 23, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	417	$59.14	$24.7K	0	Dec 21, 2020	Dec 23, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	417	$6.27	$2.6K	417	Dec 21, 2020	Dec 23, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	3,693	$49.43	$182.5K	0	Dec 1, 2020	Dec 2, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	2,604	$6.55	$17.1K	2,604	Dec 1, 2020	Dec 2, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	1,562	—	—	39,063	Dec 1, 2020	Dec 2, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	2,604	$6.55	$17.1K	5,208	Dec 1, 2020	Dec 2, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	2,604	—	—	28,646	Dec 1, 2020	Dec 2, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	2,604	—	—	57,292	Dec 1, 2020	Dec 2, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	1,562	$7.27	$11.4K	6,770	Dec 1, 2020	Dec 2, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	3,077	$48.20	$148.3K	3,693	Dec 1, 2020	Dec 2, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	416	$48.86	$20.3K	0	Nov 19, 2020	Nov 23, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	416	$6.27	$2.6K	416	Nov 19, 2020	Nov 23, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	416	—	—	2,084	Nov 19, 2020	Nov 23, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	1,563	—	—	40,625	Nov 2, 2020	Nov 4, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	1,074	$46.14	$49.6K	0	Nov 2, 2020	Nov 4, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	2,605	—	—	31,250	Nov 2, 2020	Nov 4, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	2,605	$6.55	$17.1K	2,605	Nov 2, 2020	Nov 4, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	2,604	$6.55	$17.1K	5,209	Nov 2, 2020	Nov 4, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	5,698	$45.47	$259.1K	1,074	Nov 2, 2020	Nov 4, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	1,563	$7.27	$11.4K	6,772	Nov 2, 2020	Nov 4, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	2,604	—	—	59,896	Nov 2, 2020	Nov 4, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	417	—	—	2,500	Oct 19, 2020	Oct 20, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	417	$6.27	$2.6K	417	Oct 19, 2020	Oct 20, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	417	$51.25	$21.4K	0	Oct 19, 2020	Oct 20, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	1,562	—	—	42,188	Oct 1, 2020	Oct 2, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	2,604	—	—	33,855	Oct 1, 2020	Oct 2, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	2,605	—	—	62,500	Oct 1, 2020	Oct 2, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	2,605	$6.55	$17.1K	5,209	Oct 1, 2020	Oct 2, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	2,604	$6.55	$17.1K	2,604	Oct 1, 2020	Oct 2, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	5,878	$48.46	$284.8K	893	Oct 1, 2020	Oct 2, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	893	$49.26	$44.0K	0	Oct 1, 2020	Oct 2, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	1,562	$7.27	$11.4K	6,771	Oct 1, 2020	Oct 2, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	417	—	—	2,917	Sep 21, 2020	Sep 23, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	417	$45.51	$19.0K	0	Sep 21, 2020	Sep 23, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	417	$6.27	$2.6K	417	Sep 21, 2020	Sep 23, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	2,604	—	—	65,105	Sep 1, 2020	Sep 2, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	2,604	$6.55	$17.1K	2,604	Sep 1, 2020	Sep 2, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	300	$41.75	$12.5K	0	Sep 1, 2020	Sep 2, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	2,604	$6.55	$17.1K	5,208	Sep 1, 2020	Sep 2, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	1,563	$7.27	$11.4K	6,771	Sep 1, 2020	Sep 2, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	1,563	—	—	43,750	Sep 1, 2020	Sep 2, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	6,471	$41.28	$267.1K	300	Sep 1, 2020	Sep 2, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	2,604	—	—	36,459	Sep 1, 2020	Sep 2, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	416	—	—	3,334	Aug 19, 2020	Aug 19, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	416	$41.57	$17.3K	0	Aug 19, 2020	Aug 19, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	416	$6.27	$2.6K	416	Aug 19, 2020	Aug 19, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	2,604	$6.55	$17.1K	2,604	Aug 4, 2020	Aug 5, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	1,562	$7.27	$11.4K	6,770	Aug 4, 2020	Aug 5, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	417	$6.32	$2.6K	7,187	Aug 4, 2020	Aug 5, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	2,604	—	—	67,709	Aug 4, 2020	Aug 5, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	2,604	$6.55	$17.1K	5,208	Aug 4, 2020	Aug 5, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	2,604	—	—	39,063	Aug 4, 2020	Aug 5, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	417	—	—	0	Aug 4, 2020	Aug 5, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	1,562	—	—	45,313	Aug 4, 2020	Aug 5, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	7,187	$40.00	$287.5K	0	Aug 4, 2020	Aug 5, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	417	—	—	3,750	Jul 20, 2020	Jul 21, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	417	$6.27	$2.6K	417	Jul 20, 2020	Jul 21, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	417	$40.00	$16.7K	0	Jul 20, 2020	Jul 21, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	2,604	$6.55	$17.1K	5,208	Jul 1, 2020	Jul 2, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	2,604	—	—	70,313	Jul 1, 2020	Jul 2, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	5,571	$47.17	$262.8K	1,200	Jul 1, 2020	Jul 2, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	1,563	—	—	46,875	Jul 1, 2020	Jul 2, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	1,200	$48.13	$57.8K	0	Jul 1, 2020	Jul 2, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	2,604	—	—	41,667	Jul 1, 2020	Jul 2, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	2,604	$6.55	$17.1K	2,604	Jul 1, 2020	Jul 2, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	1,563	$7.27	$11.4K	6,771	Jul 1, 2020	Jul 2, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	417	$6.32	$2.6K	417	Jun 26, 2020	Jun 30, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	417	$47.42	$19.8K	0	Jun 26, 2020	Jun 30, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	417	—	—	417	Jun 26, 2020	Jun 30, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	417	$6.32	$2.6K	417	Jun 26, 2020	Jun 30, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	417	$47.42	$19.8K	0	Jun 26, 2020	Jun 30, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	417	—	—	417	Jun 26, 2020	Jun 30, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	417	—	—	4,167	Jun 19, 2020	Jun 23, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	417	$6.27	$2.6K	417	Jun 19, 2020	Jun 23, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	417	$45.00	$18.8K	0	Jun 19, 2020	Jun 23, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	2,604	—	—	72,917	Jun 3, 2020	Jun 5, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	1,562	$7.27	$11.4K	6,770	Jun 3, 2020	Jun 5, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	1,562	—	—	48,438	Jun 3, 2020	Jun 5, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	2,604	—	—	43,271	Jun 3, 2020	Jun 5, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	6,770	$40.00	$270.8K	0	Jun 3, 2020	Jun 5, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	2,604	$6.55	$17.1K	2,604	Jun 3, 2020	Jun 5, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	2,604	$6.55	$17.1K	5,208	Jun 3, 2020	Jun 5, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	416	$42.00	$17.5K	0	May 26, 2020	May 28, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	416	$6.32	$2.6K	416	May 26, 2020	May 28, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	416	—	—	834	May 26, 2020	May 28, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	15,416	$6.27	$96.7K	94,166	May 19, 2020	May 21, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	15,416	—	—	4,584	May 19, 2020	May 21, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	246,770	$40.00	$9.87M	0	May 19, 2020	May 21, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	78,125	—	—	45,875	May 19, 2020	May 21, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	60,000	$1.98	$118.8K	60,000	May 19, 2020	May 21, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	60,000	—	—	0	May 19, 2020	May 21, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	25,000	$7.27	$181.8K	246,770	May 19, 2020	May 21, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	49,479	—	—	75,521	May 19, 2020	May 21, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	18,750	$6.32	$118.5K	78,750	May 19, 2020	May 21, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	78,125	$6.55	$511.7K	172,291	May 19, 2020	May 21, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	18,750	—	—	1,250	May 19, 2020	May 21, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	SALE Chief Business Development Off	25,000	—	—	50,000	May 19, 2020	May 21, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASE Chief Business Development Off	49,479	$6.55	$324.1K	221,770	May 19, 2020	May 21, 2020 ↗	View →
ADPT ADAPTIVE BIOTECHNOLOGIES CORP	PURCHASEGRANT Stock grant	65,000	—	—	65,000	Feb 13, 2020	Feb 18, 2020 ↗	View →

Other insiders · ADPT

Loading peer insiders…

About this filer

CIK 0001780854

ROLE

Chief Business Development Off

PRIMARY

ADPT

COMPANIES

ACTIVE SINCE

Feb 2020

MARKETPEEL · /INSIDER/0001780854DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

Sharon Benzeno

The morning brief, before the bell.